|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
H3: product analysis of fg11150-0615-2s, lotno:226898745, as found condition: the phenom 17 catheter was returned within the outer carton, inside of a sealed bio-hazard bag and a shipping box.The microwire was not returned with the catheter.In addition, the microwire size and model were not reported.Therefore, any contribution from the microwire including its compatibility for use with the catheter, could not be assessed.Visual inspection/damage location details: the catheter tip, marker, and body were examined; no damages were found, and no other anomalies were observed.Testing/analysis: the total and usable lengths of the catheter were measured to be within specifications.The catheter was flushed with water and found patent.It was then tested by running an in-house 0.016¿ mandrel through the catheter hub.The mandrel successfully passed through the catheter hub, lumen, and tip without issue.No inner coating damage was observed.Conclusion: based on the returned device, the customer complaint was not confirmed, as no issue was found with the returned catheter.The in-house mandrel could pass through the catheter hub, lumen, and tip without issue.The cause could not be determined.A possible cause includes the use of damaged/incompatible microwire.Since the microwire was not returned, any contribution of the microwire to the reported issue could not be determined.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|